BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24368107)

  • 21. In vitro and in vivo evaluation of tegaserod maleate pH-dependent tablets.
    Zhang SQ; Thumma S; Chen GH; Deng WB; Repka MA; Li SM
    Eur J Pharm Biopharm; 2008 May; 69(1):247-54. PubMed ID: 18037278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on pulsatile release tablets of diltiazem hydrochloride in explosion way].
    Fan TY; Wei SL; Yan WW; Ding WX
    Yao Xue Xue Bao; 2002 Mar; 37(3):221-5. PubMed ID: 12579768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide.
    Gao Y; Gao Y; Yin F; Wang M; Wang Z; Ye T; Yang Y; Pan WS; Yang X
    Drug Dev Ind Pharm; 2015; 41(9):1443-51. PubMed ID: 25190152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug release mechanism of famotidine time-controlled release pellets].
    Zhang L; Chen DW; Gao ZB
    Yao Xue Xue Bao; 2006 Sep; 41(9):873-7. PubMed ID: 17111836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
    Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
    Bendas ER; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Three-Pulse Release Tablet for Amoxicillin: Preparation, Pharmacokinetic Study and Physiologically Based Pharmacokinetic Modeling.
    Li J; Chai H; Li Y; Chai X; Zhao Y; Zhao Y; Tao T; Xiang X
    PLoS One; 2016; 11(8):e0160260. PubMed ID: 27479702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and in vitro-in vivo evaluation of double layer coated and matrix sustained release pellet formulations of diclofenac potassium.
    Fu J; Wang X; Xu L; Meng J; Weng Y; Li G; He H; Tang X
    Int J Pharm; 2011 Mar; 406(1-2):84-90. PubMed ID: 21219996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
    Sosnowska K; Winnicka K; Czajkowska-Kośnik A
    Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Enalapril.
    Verbeeck RK; Kanfer I; Löbenberg R; Abrahamsson B; Cristofoletti R; Groot DW; Langguth P; Polli JE; Parr A; Shah VP; Mehta M; Dressman JB
    J Pharm Sci; 2017 Aug; 106(8):1933-1943. PubMed ID: 28435140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of pH-dependent modified-release pellets of urapidil to improve its bioavailability.
    He H; Li H; Tang X
    Pharm Dev Technol; 2011 Jun; 16(3):212-8. PubMed ID: 20151942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
    Singh G; Pai RS
    J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Piecewise function parameters as responses of the design of experiment in the development of a pulsatile release chronopharmaceutical system.
    Vonica-Gligor AL; Tomuţă I; Leucuţa SE
    Acta Pharm; 2016 Jun; 66(2):173-89. PubMed ID: 27279062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proposal of a new degradation mechanism of enalapril maleate and improvement of enalapril maleate stability in tablet formulation with different stabilizers.
    Chen J; Zhang LH; Xu RJ; Bu NJ; Zhang L
    Pharmazie; 2014 Apr; 69(4):277-80. PubMed ID: 24791591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
    Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of a matrix type multiple-unit gastro retentive floating drug delivery system for captopril based on gas formation technique: in vitro evaluation.
    Meka L; Kesavan B; Chinnala KM; Vobalaboina V; Yamsani MR
    AAPS PharmSciTech; 2008; 9(2):612-9. PubMed ID: 18459051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.